The results of the evaluations showed that our method could clearly distinguish between ACPs/AMPs and non-ACPs/AMPs, and the potential of TriNet for identifying ACPs/AMPs will help researchers develop small-peptide drugs targeting cancer cells or other pathogens, such as bacteria, fungi, and viruses. The gene discussed is AASDHPPT; the disease is cancer.